HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#111 / 200 Total
MBIO - Mustang Bio Inc - Stock Price Chart
TickerMBIO [NASD]
CompanyMustang Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap9.36MEPS (ttm)-1.79
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y18.87%
P/S-EPS next 5Y-
P/B-EPS Q/Q96.89%
Dividend-Sales Q/Q-
Insider Own15.78%Inst Own5.72%
Insider Trans0.00%Inst Trans3.19%
Short Float0.85%EarningsNov 12
Analyst Recom1.00Target Price10.00
Avg Volume8.67M52W Range0.13 - 1.52
Today 08:00AM Mustang Bio Announces Reverse Stock Split (GlobeNewswire) -36.31%
Nov-12-24 08:30AM Mustang Bio Receives Positive Listing Determination from Nasdaq (GlobeNewswire)
Nov-08-24 06:36AM Mustang Bios MB-108 receives FDA orphan drug status for glioma treatment (Pharmaceutical Technology)
Nov-07-24 08:30AM Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma (GlobeNewswire)
Oct-26-24 05:20PM Mustang Bio Secures $4M through Strategic Warrant Agreement (TipRanks)
Oct-24-24 02:10PM Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds (GlobeNewswire)
Jun-28-24 08:00AM Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB) (GlobeNewswire)
Jun-21-24 04:01PM Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
Jun-20-24 05:26PM Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike (PR Newswire) -34.07%
08:00AM Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
XXII - 22nd Century Group Inc - Stock Price Chart
TickerXXII [NASD]
Company22nd Century Group Inc
CountryUSA
IndustryTobacco
Market Cap3.91MEPS (ttm)-2978.08
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-49.91%
P/S0.14EPS next 5Y-
P/B0.44EPS Q/Q99.07%
Dividend-Sales Q/Q-66.62%
Insider Own15.06%Inst Own6.07%
Insider Trans87.72%Inst Trans-
Short Float19.46%EarningsNov 12/b
Analyst Recom2.00Target Price7192.80
Avg Volume488.94K52W Range3.90 - 581.85
Today 09:25AM Washington Post Story Featuring 22nd Century VLN Products Highlights Proposed FDA Reduced Nicotine Content Policy Could Initially Benefit An Estimated 13 Million Smokers (GlobeNewswire) +17.83%
Jan-13-25 07:30AM 22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes (GlobeNewswire) +22.70%
Jan-07-25 08:30AM 22nd Century Group Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly (GlobeNewswire)
Dec-13-24 08:45AM 22nd Century Announces 1-for-135 Reverse Stock Split (Newsfile) -33.20%
Dec-12-24 11:31AM 22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes (Newsfile)
Nov-13-24 02:05AM 22nd Century Group Inc (XXII) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... (GuruFocus.com)
Nov-12-24 06:00AM 22nd Century Group Reports Third Quarter 2024 Financial Results (Newsfile)
Nov-07-24 11:05AM 22nd Century Group (XXII) to Announce Third Quarter 2024 Results on November 12, 2024 (Newsfile) +14.56%
Oct-21-24 09:00AM 22nd Century Group to Present at the LD Micro Main Event XVII on October 30 in Los Angeles (Newsfile)
Oct-08-24 08:00AM 22nd Century Regains Compliance with Nasdaq Stockholders' Equity Requirement (Newsfile) -5.98%
ITCI - Intra-Cellular Therapies Inc - Stock Price Chart
TickerITCI [NASD]
CompanyIntra-Cellular Therapies Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap13.46BEPS (ttm)-0.86
P/E-EPS this Y57.40%
Forward P/E344.08EPS next Y159.32%
PEG-EPS past 5Y12.47%
P/S21.93EPS next 5Y-
P/B11.75EPS Q/Q1.35%
Dividend-Sales Q/Q39.00%
Insider Own6.53%Inst Own90.68%
Insider Trans-6.10%Inst Trans-0.74%
Short Float2.00%EarningsOct 30/b
Analyst Recom2.14Target Price121.36
Avg Volume1.19M52W Range62.78 - 128.00
Today 12:13PM J&J to leverage Intra-Cellular Therapies neurology portfolio (Pharmaceutical Technology)
09:53AM Why Intra-Cellular (ITCI) Led the Monday Upsurge? (Insider Monkey)
08:56AM ITCI Poised for Turnaround Amid Rising Mental Health Concerns (GuruFocus.com)
06:58AM Intra-Cellular (ITCI) Moves 34.1% Higher: Will This Strength Last? (Zacks)
05:51AM ITCI Stock Surges 34% as J&J Reveals $14.6 Billion Acquisition Plan (GuruFocus.com)
Jan-13-25 04:47PM JPMorgan Healthcare Conference: AI, billion-dollar deals (Yahoo Finance Video) +34.07%
04:24PM These Stocks Are Moving the Most Today: Micron, Intra-Cellular Therapies, and More (Barrons.com)
04:19PM J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug (Investor's Business Daily)
03:13PM Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal (The Wall Street Journal)
10:30AM J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders (Associated Press Finance)
T - AT&T, Inc - Stock Price Chart
TickerT [NYSE, S&P 500]
CompanyAT&T, Inc
CountryUSA
IndustryTelecom Services
Market Cap155.70BEPS (ttm)1.23
P/E17.64EPS this Y-9.11%
Forward P/E10.16EPS next Y-2.49%
PEG14.70EPS past 5Y-7.15%
P/S1.28EPS next 5Y1.20%
P/B1.52EPS Q/Q-106.55%
Dividend5.14%Sales Q/Q-0.45%
Insider Own0.27%Inst Own61.80%
Insider Trans0.00%Inst Trans2.42%
Short Float1.47%EarningsJan 27/b
Analyst Recom2.07Target Price25.65
Avg Volume34.66M52W Range15.94 - 24.03
Today 11:02AM Would You Spend $70 a Month for Sports Channels? DirecTV Hopes You Will (Investopedia)
Jan-13-25 05:45PM AT&T (T) Stock Sinks As Market Gains: What You Should Know (Zacks)
09:05AM Jim Cramer Prefers T-Mobile Us (TMUS) Over AT&T Heres Why (Insider Monkey)
04:01AM Three Reasons to Avoid T and One Stock to Buy Instead (StockStory)
Jan-12-25 03:30AM 3 Cheap Tech Stocks That Are Screaming Buys in January (Motley Fool)
Jan-10-25 07:11PM Analyst Report: AT&T Inc. (Morningstar Research)
10:54AM ESPN, FOX, Warner Bros. Discovery Abandon Venu Sports Streamer Prior to Launch (Investopedia)
10:00AM Venu Sports the proposed sports streaming venture between ESPN, Fox, and Warner Bros. is no more (Yahoo Finance)
Jan-09-25 11:03AM AT&T hopes to win back trust from customers with generous offer (TheStreet)
10:00AM Cyber Startup Wiz Names New CFO as It Weighs an IPO (The Wall Street Journal)
VWO - Vanguard FTSE Emerging Markets ETF - Stock Price Chart
TickerVWO [NYSE]
CompanyVanguard FTSE Emerging Markets ETF
CountryUSA
IndustryExchange Traded Fund
CategoryGlobal or ExUS Equities - Broad / Regional
IndexFTSE Emerg Mkts All Cap China A Inclusio...
TagsEmerging, equity
Sector/Theme Region
Dividend3.27%Active/Passive
Total Holdings5891AUM76.44B
Flows% 1M1.09%Flows% 3M1.11%
Flows% YTD0.01%Flows% 1Y
Return% 1Y6.94%Return% 3Y-0.02%
Return% 5Y1.56%Return% 10Y
NAV% Expense
Avg Volume7.72M52W Range38.83 - 49.57
Sep-27-24 08:00AM What Is an Emerging Markets ETF? The Complete Guide (etf.com)
Apr-23-24 08:00AM Investors Love This Under the Radar Emerging Markets ETF (etf.com)
Jan-20-23 06:00PM Investors Pour Money Into Emerging Market ETFs (etf.com)
Jan-19-23 05:15PM Nuances of Advising Young Tech Workers (ETF.com)
Nov-29-22 02:15PM Ex-US Funds Soared in November (ETF.com)
Oct-06-22 12:50PM 3 ETFs to Invest Globally in Q4 2022 (Investopedia)
Jul-13-22 03:27PM Sri Lankas economic collapse ringing alarm bells for emerging markets: Expert (Yahoo Finance)
Jul-12-22 11:58AM Sri Lankas economic collapse ringing alarm bells for emerging markets: Expert (Yahoo Finance Video)
Jul-07-22 04:00PM 'Reducing inflation will come at a great cost': Ray Dalio warns that the Fed will likely trigger something far worse than high prices. Here's what he likes today (MoneyWise)
May-27-22 09:40AM Cash is still trash Billionaire Ray Dalio says keeping money in a savings account is not safe. Heres what he holds instead (MoneyWise)
LYG - Lloyds Banking Group plc ADR - Stock Price Chart
TickerLYG [NYSE]
CompanyLloyds Banking Group plc ADR
CountryUnited Kingdom
IndustryBanks - Regional
Market Cap40.12BEPS (ttm)-
P/E-EPS this Y-8.37%
Forward P/E8.10EPS next Y-5.69%
PEG-EPS past 5Y4.99%
P/S1.12EPS next 5Y0.82%
P/B0.75EPS Q/Q-9.54%
Dividend5.88%Sales Q/Q82.22%
Insider Own0.03%Inst Own2.59%
Insider Trans0.00%Inst Trans0.00%
Short Float0.07%EarningsOct 23/b
Analyst Recom2.63Target Price3.29
Avg Volume10.45M52W Range2.00 - 3.24
Jan-13-25 07:01AM Lloyds Bank will tie its senior bankers 2024 bonuses to their office attendance (Fortune)
Jan-10-25 07:41PM Analyst Report: Lloyds Banking Group plc (Morningstar Research)
01:06PM Is Lloyds Banking Group plc (LYG) Among the Best Bank Penny Stocks to Buy According to Hedge Funds? (Insider Monkey)
07:29AM Lloyds Banking Group allows branch access across brands (Retail Banker International)
Dec-10-24 10:53AM Lloyds CEO warns motor finance ruling threatens UK economy (Motor Finance)
Dec-06-24 11:26AM Lloyds Banking Group: Rising from the Depths of the 2008 Global Financial Crisis (GuruFocus.com)
Dec-03-24 08:28AM Lloyds Plans SRT Tied to £1 Billion of UK Restructured Mortgages (Bloomberg)
Dec-01-24 03:30AM Britains Jobs Statistics Crisis Gives Banks a Growing Headache (Bloomberg)
Nov-28-24 07:01AM Lloyds Banking to Redeem £500 Million Securities (TipRanks)
Nov-18-24 01:00AM Lloyds swamping car finance lawyers with 200,000 legal letters (The Telegraph)
ARBE - Arbe Robotics Ltd - Stock Price Chart
TickerARBE [NASD]
CompanyArbe Robotics Ltd
CountryIsrael
IndustrySoftware - Infrastructure
Market Cap284.19MEPS (ttm)-0.59
P/E-EPS this Y14.55%
Forward P/E-EPS next Y9.34%
PEG-EPS past 5Y-
P/S278.61EPS next 5Y-
P/B13.54EPS Q/Q-2.85%
Dividend-Sales Q/Q-74.32%
Insider Own34.41%Inst Own19.90%
Insider Trans0.00%Inst Trans8.54%
Short Float1.93%EarningsNov 27/b
Analyst Recom1.00Target Price3.33
Avg Volume5.26M52W Range1.39 - 5.09
Jan-07-25 03:45PM Arbe Robotics Ltd. Announces $29 Million Underwritten Registered Direct Offering (GlobeNewswire) -6.00%
Jan-06-25 08:00AM Arbe Collaborates with NVIDIA to Enhance Radar-Based Free Space Mapping and AI-Driven Capabilities (PR Newswire) +52.09%
Jan-02-25 08:00AM Arbe to Present at 27th Annual Needham Growth Conference (GlobeNewswire) +9.68%
Nov-27-24 07:00AM Arbe Announces Q3 2024 Financial Results (PR Newswire) -6.81%
Nov-12-24 09:00AM Arbe to Participate at ROTH 13th Annual Technology Conference (PR Newswire)
Nov-06-24 08:00AM Arbe to Announce Q3 2024 Financial Results and Hold a Conference Call on November 27 (PR Newswire)
Nov-04-24 04:45PM Arbe Robotics, Ltd. Announces Closing of up to $49 Million Public Offering (GlobeNewswire)
Nov-01-24 08:56AM Arbe Robotics, Ltd. Announces Pricing of up to $49 Million Public Offering (GlobeNewswire)
Oct-31-24 04:02PM Arbe Robotics, Ltd. Announces Proposed Public Offering (PR Newswire)
Sep-26-24 09:00AM Arbe's Tier-1 HiRain Develops Radar-Based ADAS System, Replacing LiDAR for Car Automaker (PR Newswire)
EYEN - Eyenovia Inc - Stock Price Chart
TickerEYEN [NASD]
CompanyEyenovia Inc
CountryUSA
IndustryBiotechnology
Market Cap9.27MEPS (ttm)-0.73
P/E-EPS this Y6.06%
Forward P/E-EPS next Y25.81%
PEG-EPS past 5Y18.26%
P/S309.11EPS next 5Y-
P/B1.93EPS Q/Q37.96%
Dividend-Sales Q/Q35.64%
Insider Own1.92%Inst Own11.96%
Insider Trans3.74%Inst Trans43.71%
Short Float4.20%EarningsNov 12/a
Analyst Recom3.00Target Price2.00
Avg Volume21.87M52W Range0.08 - 2.57
Jan-06-25 07:00AM Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives (GlobeNewswire) +9.17%
Dec-06-24 08:00AM Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering (GlobeNewswire) -9.49%
Nov-25-24 08:00AM Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering (GlobeNewswire) -17.38%
Nov-23-24 07:05AM Eyenovia taking additional actions to reduce personnel-related costs by over 70% (TipRanks)
Nov-22-24 07:00AM Eyenovia Provides Update on Restructuring Efforts (GlobeNewswire)
Nov-19-24 06:15AM Eyenovia downgraded to Neutral from Buy at H.C. Wainwright (TipRanks) +7.39%
Nov-18-24 07:38AM Eyenovia stock plummets following Phase III myopia trial failure (Clinical Trials Arena) +8.93%
Nov-15-24 01:15PM Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline (Benzinga) -70.04%
07:00AM Eyenovia Provides Update on Phase 3 CHAPERONE Study (GlobeNewswire)
Nov-13-24 02:17AM Eyenovia Inc (EYEN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges (GuruFocus.com) -19.35%
RXRX - Recursion Pharmaceuticals Inc - Stock Price Chart
TickerRXRX [NASD, RUT]
CompanyRecursion Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap2.50BEPS (ttm)-1.53
P/E-EPS this Y2.85%
Forward P/E-EPS next Y-7.08%
PEG-EPS past 5Y-43.41%
P/S38.34EPS next 5Y-
P/B3.49EPS Q/Q21.84%
Dividend-Sales Q/Q147.62%
Insider Own17.21%Inst Own57.88%
Insider Trans-0.73%Inst Trans2.32%
Short Float22.79%EarningsNov 06/a
Analyst Recom2.43Target Price9.17
Avg Volume11.52M52W Range5.60 - 15.74
Jan-10-25 09:55AM Does Recursion Pharmaceuticals (RXRX) Have the Potential to Rally 27.96% as Wall Street Analysts Expect? (Zacks) -5.23%
Jan-08-25 07:26AM Recursion Pharmaceuticals price target lowered to $10 from $12 at BofA (TipRanks)
06:32AM AMD Invests in Drug-Discovery Company Absci in Push to Sell AI Chips (The Wall Street Journal)
Jan-07-25 09:15AM Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical Trials, Targeting High Unmet Needs in Hematologic Malignancies, Small-Cell Lung Cancer, & More (GlobeNewswire) -5.79%
Jan-06-25 08:30AM Recursion to Present at 43rd Annual JP Morgan Healthcare Conference (GlobeNewswire)
Dec-26-24 11:26AM Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment (PR Newswire) +5.80%
Dec-21-24 09:00AM Is Recursion Pharmaceuticals Stock a Millionaire Maker? (Motley Fool)
08:25AM 1 Artificial Intelligence (AI) Stock That Could Soar in 2025 (Motley Fool)
Dec-20-24 04:05PM Recursion Pharmaceuticals Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules (GlobeNewswire) +15.92%
Dec-15-24 08:04AM Jim Cramer Says He Was Wrong on NVIDIA Holding Recursion Pharmaceuticals (RXRX) (Insider Monkey)
UBER - Uber Technologies Inc - Stock Price Chart
TickerUBER [NYSE, S&P 500]
CompanyUber Technologies Inc
CountryUSA
IndustrySoftware - Application
Market Cap137.31BEPS (ttm)2.04
P/E31.91EPS this Y108.15%
Forward P/E27.34EPS next Y31.70%
PEG0.78EPS past 5Y-
P/S3.27EPS next 5Y40.76%
P/B9.28EPS Q/Q1129.61%
Dividend-Sales Q/Q20.40%
Insider Own3.89%Inst Own79.97%
Insider Trans-0.69%Inst Trans0.75%
Short Float2.59%EarningsOct 31/b
Analyst Recom1.36Target Price89.95
Avg Volume23.87M52W Range54.84 - 87.00
Today 01:09PM Body Scanners, AI Mirrors and Smart Carts: Go Inside the Latest in Shopping Tech (Investopedia)
09:25AM Uber price target lowered to $90 from $95 at Morgan Stanley (TipRanks)
07:50AM Analyst Says People Selling Uber Technologies (UBER) On Robotaxi Threat Completely Miss The Story (Insider Monkey)
Jan-13-25 05:45PM Uber Technologies (UBER) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
04:00PM Why Uber Technologies (UBER) is Skyrocketing in 2025? (Insider Monkey)
03:25PM Uber (UBER) Faces Challenges but Cramer Sees Opportunity Amid Slow Growth (Insider Monkey)
03:17PM On The Hunt For Magnificent Earnings Growth? Check These 7 Stocks. (Investor's Business Daily)
12:25PM Uber Technologies, Inc. (UBER): A Bull Case Theory (Insider Monkey)
10:31AM Revolutionizing Smartphone Use with a $10M+ Fundraising Triumph (TheStreet)
Jan-11-25 07:17PM Is Uber Technologies, Inc. (UBER) Among the Best Growth Stocks to Buy and Hold in 2025? (Insider Monkey)
1⋯7891011121314151617⋯20
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.